Literature DB >> 1543969

Epidemiology of asthma.

H R Anderson1.   

Abstract

Asthma remains an important cause of distress and disability for patients of all ages and may be increasing in severity. Mortality is low in children but increases steeply with age where it is associated with chronic obstructive lung disease. The causes of asthma are poorly understood.

Entities:  

Mesh：

Year:  1992        PMID： 1543969

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN： 0007-1064


  6 in total

Review 1.  Treatment of childhood asthma. Options and rationale for inhaled therapy.

Authors:  C V Powell; M L Everard
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 2.  Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

Authors:  D H Peters; D Faulds
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

3.  Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.

Authors:  P Gustafsson; J Tsanakas; M Gold; R Primhak; M Radford; E Gillies
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

4.  A placebo controlled trial of fluticasone propionate in asthmatic children.

Authors:  C A MacKenzie; E G Weinberg; E Tabachnik; M Taylor; J Havnen; K Crescenzi
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

5.  Occupational asthma: measures of frequency from four countries.

Authors:  S Meredith; H Nordman
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

Review 6.  Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.

Authors:  Malcolm Brodlie; Atul Gupta; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Francine M Ducharme; Michael C McKean
Journal:  Cochrane Database Syst Rev       Date:  2015-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.